Home › NCT06085625
A Randomized Control Trial for Patient Reported Outcomes and Safety in Outpatient Thyroid Lobectomy
RecruitingPhase 2
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: 1. Patients ≥18 years of age 2. Patients undergoing initial partial or complete thyroid lobectomy 3. English and non-English speaking patients are eligible Exclusion Criteria: 1. Increased risk of bleeding (e.g., Aspirin, antiplatelet therapy, or anticoagulation that cannot be held 5 days before surgery, baseline thrombocytopenia \<50,000/µL) 2. Pre-existing medical comorbidities or poor performance status (Eastern Cooperative Oncology Group performance status \>2) that would otherwise dictate overnight in-hospital postoperative observation 3. Increased distance of residence from index hospital (\>50 miles) or inability to stay within the targeted area (\<50 miles) postoperatively prohibiting timely return to the index hospital in emergent situations 4. Lives alone or unable to independently perform Activities of Daily Living and no available caregiver in the immediate postoperative period (POD 0-3) 5. Pregnant women will not be included in this study
About the study
To compare same-day discharge and overnight (or longer) observation practices and learn more about the differences in patient preferences, safety outcomes, and economic and resource impact
What is being tested
- Pre-Surgery Survey (behavioral)
- Post-Surgery Surveys (behavioral)
Sponsor: M.D. Anderson Cancer Center · Participants: 224 · Started: Nov 26, 2024
Contact the study team
- Paul Graham, M D · Phone: (832) 829-2547
Official record on ClinicalTrials.gov — NCT06085625
Locations in the U.S.
| Texas | M D Anderson Cancer Center, Houston |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.